Background: Ruling out somatic bowel disease, such as inflammatory bowel disease (IBD), is an important goal in the management of abdominal complaints...
Keywords: biomarkers, enzyme-linked immunosorbent assay (ELISA), fecal calprotectin, fecal lactoferrin, inflammatory bowel disease, irritable bowel syndrome